ArticleEuropean journal of epidemiology2020
Healthy lifestyle and the risk of pancreatic cancer in the EPIC study.
Abstract read
In one paragraph
Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lifestyle scores and their potential to estimate the risk of multiple non-communicable disease-related endpoints: a systematic review.BMC public health · 2025Pooled it
- Association of Life's Essential 8 Score With Incident Pancreatic Cancer: A Prospective Cohort Study in Shanghai, China.Cancer science · 2026Article
- Evaluating body composition, the eating behavior scale, and the healthy lifestyle index in female Jordanian adults with metabolic syndrome: a cross-sectional study.Diabetology & metabolic syndrome · 2025Article
- The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021.NPJ precision oncology · 2025Article
- The association between the healthy lifestyle index and MRI-derived body composition measurements in the UK Biobank study.Scientific reports · 2025Article
- Colorectal Cancer and Central Obesity.JAMA network open · 2025Article
- Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT.Nutrients · 2024Article
- Article
- Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in Men.Biomedicines · 2024Article
- Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis.Molecular biotechnology · 2024Article
- Advancements in Early Detection and Screening Strategies for Pancreatic Cancer: From Genetic Susceptibility to Novel Biomarkers.Journal of clinical medicine · 2024Review
- On the use of the healthy lifestyle index to investigate specific disease outcomes.Scientific reports · 2024Article
- Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort.BMC medicine · 2024Article
- Childhood and adulthood passive and active smoking, and the ABO group as risk factors for pancreatic cancer in women.United European gastroenterology journal · 2024Article
- Pairwise association of key lifestyle factors and risk of solid cancers - A prospective pooled multi-cohort register study.Preventive medicine reports · 2024Article
- Association of genetic risk and lifestyle with pancreatic cancer and their age dependency: a large prospective cohort study in the UK Biobank.BMC medicine · 2023Article
- Systemic treatment for advanced pancreatic cancer.World journal of gastrointestinal oncology · 2023Review
- Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions.Biomedicines · 2023Review
- Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.Cancer discovery · 2023Article
- Gender differences in metabolic syndrome and its components in southern china using a healthy lifestyle index: a cross-sectional study.BMC public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors.
Sabine NaudinNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.ORCID http://orcid.org/0000-0003-1049-6225
Vivian ViallonNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
Dana HashimDepartment of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Heinz FreislingNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
Mazda JenabNutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Elisabete WeiderpassDirector Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Flavie PerrierNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
Fiona McKenzieEnvironment and Radiation section, Agency for Research on Cancer, World Health Organization, Lyon, France.
H Bas Bueno-de-MesquitaDepartement for Determinants of Chronic Diseases (Former), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Christina C DahmSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kim OvervadSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Francesca R ManciniCESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
Vinciane ReboursPancreatology Department, Beaujon Hospital, AP-HP, Clichy, France.
Marie-Christine Boutron-RuaultCESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Manuela BergmannGerman Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.
Heiner BoeingGerman Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.
Eleni PeppaHellenic Health Foundation, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Giovana MasalaCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
Salvatore PanicoDepartment of Clinical and Experimental Medecine, University Federico II, Naples, Italy.
Rosario TuminoCancer Registry and Histopathology Department, Civic M.P.Arezzo Hospital, Ragusa, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University, Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Carla H van GilsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Charlotta RylanderDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Kristin Benjaminsen BorchDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
María Dolores Chirlaque LópezDepartment of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
Maria-Jose SánchezSpanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
Eva ArdanazSpanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
José Ramón QuirósPublic Health Directorate, Asturias, Spain.
Pilar Amiano ExezarretaSpanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
Malin SundDepartment of Surgical and Preoperative Sciences, Umeå University, Umeå, Sweden.
Isabel DrakeDepartment of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Sara RegnérDepartment of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Nick WarehamMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Marc J GunterNutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Eric J DuellUnit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Paul BrennanGenetic Epidemiology Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Pietro FerrariNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France. ferrarip@iarc.fr.
Funding
Cancer Research UK 14136Cancer Research UK A16491Cancer Research UK A19170Cancer Research UK C570/A16491Cancer Research UK C8221/A19170French Ministry of Health GR-IARC-2003-09-12-01Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_UU_12015/1Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1Medical Research Council (UK) 1000143Medical Research Council (UK) MR/M012190/1Région Auvergne-Rhône-Alpes ADR 2016Wellcome TrustWorld Health Organization 001
Abstract
Pancreatic cancer (PC) is a highly fatal cancer with currently limited opportunities for early detection and effective treatment. Modifiable factors may offer pathways for primary prevention. In this study, the association between the Healthy Lifestyle Index (HLI) and PC risk was examined. Within the European Prospective Investigation into Cancer and Nutrition cohort, 1113 incident PC (57% women) were diagnosed from 400,577 participants followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary exposure, physical activity and, in turn, overall and central adiposity using BMI (HLI
Indexed as
ExerciseHealthy LifestyleAlcohol DrinkingCohort StudiesFemaleHumansIncidenceMaleNutritional StatusObesityObesity, AbdominalPancreatic NeoplasmsProportional Hazards ModelsProspective StudiesRisk FactorsSmokingEPICHealthy Lifestyle IndexPancreatic cancerPopulation attributable fractionProspective study
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.